![Lars WORTMANN | Principal Scientist | Boehringer Ingelheim, Ingelheim am Rhein | BIRIT | Medicinal Chemistry Lars WORTMANN | Principal Scientist | Boehringer Ingelheim, Ingelheim am Rhein | BIRIT | Medicinal Chemistry](https://i1.rgstatic.net/ii/profile.image/720300907978760-1548744527486_Q512/Lars_Wortmann.jpg)
Lars WORTMANN | Principal Scientist | Boehringer Ingelheim, Ingelheim am Rhein | BIRIT | Medicinal Chemistry
![Venous thromboembolism prevention and treatment: expanding the rivaroxaban knowledge base with real-life data – topic of research paper in Clinical medicine. Download scholarly article PDF and read for free on CyberLeninka open Venous thromboembolism prevention and treatment: expanding the rivaroxaban knowledge base with real-life data – topic of research paper in Clinical medicine. Download scholarly article PDF and read for free on CyberLeninka open](https://cyberleninka.org/viewer_images/913100/f/1.png)
Venous thromboembolism prevention and treatment: expanding the rivaroxaban knowledge base with real-life data – topic of research paper in Clinical medicine. Download scholarly article PDF and read for free on CyberLeninka open
Haemodynamic profile of an inhibitor of phosphodiesterase III, adibendan (BM 14.478): comparison with nitroprusside and dobutamine in conscious dogs. - Abstract - Europe PMC
![PDF) Structural basis for translational shutdown and immune evasion by the Nsp1 protein of SARS-CoV-2 PDF) Structural basis for translational shutdown and immune evasion by the Nsp1 protein of SARS-CoV-2](https://i1.rgstatic.net/publication/341482883_Structural_basis_for_translational_shutdown_and_immune_evasion_by_the_Nsp1_protein_of_SARS-CoV-2/links/5ec507f2299bf1c09acc04f4/largepreview.png)
PDF) Structural basis for translational shutdown and immune evasion by the Nsp1 protein of SARS-CoV-2
![Lars WORTMANN | Principal Scientist | Boehringer Ingelheim, Ingelheim am Rhein | BIRIT | Medicinal Chemistry Lars WORTMANN | Principal Scientist | Boehringer Ingelheim, Ingelheim am Rhein | BIRIT | Medicinal Chemistry](https://www.researchgate.net/profile/Katrin_Juenemann/publication/341497838/figure/fig2/AS:921103190986753@1596619522755/Schematic-representation-of-the-HaloTag-dTag-and-Nanobody-approach-a-The-HaloTag_Q320.jpg)
Lars WORTMANN | Principal Scientist | Boehringer Ingelheim, Ingelheim am Rhein | BIRIT | Medicinal Chemistry
![Lars WORTMANN | Principal Scientist | Boehringer Ingelheim, Ingelheim am Rhein | BIRIT | Medicinal Chemistry Lars WORTMANN | Principal Scientist | Boehringer Ingelheim, Ingelheim am Rhein | BIRIT | Medicinal Chemistry](https://www.researchgate.net/publication/341497669/figure/fig2/AS:933971001090048@1599687447326/Abbildung-6-Strukturen-typischer-E3-Ligase-Binder-a-Die-VHL-bindenden-Peptidomimetika_Q320.jpg)
Lars WORTMANN | Principal Scientist | Boehringer Ingelheim, Ingelheim am Rhein | BIRIT | Medicinal Chemistry
![Lars WORTMANN | Principal Scientist | Boehringer Ingelheim, Ingelheim am Rhein | BIRIT | Medicinal Chemistry Lars WORTMANN | Principal Scientist | Boehringer Ingelheim, Ingelheim am Rhein | BIRIT | Medicinal Chemistry](https://www.researchgate.net/publication/341497669/figure/fig4/AS:933971001102338@1599687447624/Abbildung-9-Schematische-Darstellung-von-TRIM-Away-und-bioPROTACs-a-TRIM21-erkennt_Q320.jpg)